# Peri-Articular-Multimodal Drug and Oral Celecoxib in Management of Postoperative Pain of Total Knee Arthroplasty

> **NCT05324995** · PHASE2 · COMPLETED · sponsor: **Isfahan University of Medical Sciences** · enrollment: 146 (actual)

## Conditions studied

- Postoperative Pain
- Total Knee Arthroplasty

## Interventions

- **DRUG:** Multimodal Drug
- **DRUG:** epinephrine
- **DRUG:** celecoxib

## Key facts

- **NCT ID:** NCT05324995
- **Lead sponsor:** Isfahan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2022-02-01
- **Final completion:** 2022-03-01
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2022-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05324995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05324995, "Peri-Articular-Multimodal Drug and Oral Celecoxib in Management of Postoperative Pain of Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05324995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*